Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)
Business Type Supplier, Trading Company, Wholesaler Employee Count 10 Establishment 2021 Working Days To GST NO 27AAIFF2262P1Z0 Related Products Explore Related Categories More Products From This Seller Seller Details GST - 27AAIFF2262P1Z0 Mumbai, Maharashtra Partner Mr Praful Members since 2 Years Address 8_B, First Floor, Haroon Building, Kalbadevi, Shamaldas Gandhi Marg, Princess Street, Mumbai, Maharashtra, 400002, India Report incorrect details
ZORYVE cream, a next-generation topical phosphodiesterase 4 (PDE4) inhibitor, demonstrated rapid and sustained itch reduction from the first application, targeting itch-signaling nerves and inflammatory pathways
The future developments are worth watching closely